NEFL and primary progressive multiple sclerosis: Furthermore, the predictive value of this potential marker has been shown in PPMS patients treated with high-efficacy therapies; high levels of NfL at baseline predicted the risk of confirmed disability progression or occurrence of PIRA within few years of follow-up [74].